TVTX logo

Travere Therapeutics (TVTX) Retained earnings

annual retained earnings:

-$1.45B-$321.55M(-28.57%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual retained earnings is -$1.45 billion, with the most recent change of -$321.55 million (-28.57%) on December 31, 2024.
  • During the last 3 years, TVTX annual retained earnings has fallen by -$681.20 million (-88.93%).
  • TVTX annual retained earnings is now -1192947.82% below its all-time high of -$121.30 thousand, reached on February 28, 2011.

Performance

TVTX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly retained earnings:

-$1.49B-$41.23M(-2.85%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly retained earnings is -$1.49 billion, with the most recent change of -$41.23 million (-2.85%) on March 31, 2025.
  • Over the past year, TVTX quarterly retained earnings has dropped by -$226.71 million (-17.97%).
  • TVTX quarterly retained earnings is now -1226934.62% below its all-time high of -$121.30 thousand, reached on February 28, 2011.

Performance

TVTX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TVTX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.6%-18.0%
3 y3 years-88.9%-83.4%
5 y5 years-247.5%-258.1%

TVTX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-88.9%at low-69.4%at low
5 y5-year-247.5%at low-237.0%at low
alltimeall time<-9999.0%at low<-9999.0%at low

TVTX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$1.49B(+2.8%)
Dec 2024
-$1.45B(+28.6%)
-$1.45B(+4.3%)
Sep 2024
-
-$1.39B(+4.1%)
Jun 2024
-
-$1.33B(+5.6%)
Mar 2024
-
-$1.26B(+12.1%)
Dec 2023
-$1.13B(+11.0%)
-$1.13B(+8.7%)
Sep 2023
-
-$1.04B(-12.7%)
Jun 2023
-
-$1.19B(+7.8%)
Mar 2023
-
-$1.10B(+8.5%)
Dec 2022
-$1.01B(+32.4%)
-$1.01B(+6.9%)
Sep 2022
-
-$948.40M(+7.9%)
Jun 2022
-
-$878.74M(+8.3%)
Mar 2022
-
-$811.71M(+6.0%)
Dec 2021
-$765.97M(+30.7%)
-$765.97M(+7.2%)
Sep 2021
-
-$714.39M(+5.3%)
Jun 2021
-
-$678.75M(+6.1%)
Mar 2021
-
-$639.74M(+9.2%)
Dec 2020
-$585.88M(+40.7%)
-$585.88M(+26.2%)
Sep 2020
-
-$464.25M(+5.1%)
Jun 2020
-
-$441.70M(+6.3%)
Mar 2020
-
-$415.64M(-0.2%)
Dec 2019
-$416.44M(+54.2%)
-$416.44M(+7.8%)
Sep 2019
-
-$386.19M(+10.4%)
Jun 2019
-
-$349.69M(+12.4%)
Mar 2019
-
-$310.99M(+15.2%)
Dec 2018
-$270.02M(+52.0%)
-$270.02M(+2.8%)
Sep 2018
-
-$262.56M(+26.2%)
Jun 2018
-
-$208.05M(+12.0%)
Mar 2018
-
-$185.72M(+4.5%)
DateAnnualQuarterly
Dec 2017
-$177.66M(+57.1%)
-$177.66M(+11.0%)
Sep 2017
-
-$160.04M(+12.5%)
Jun 2017
-
-$142.24M(+10.3%)
Mar 2017
-
-$129.01M(+14.1%)
Dec 2016
-$113.06M(+73.5%)
-$113.06M(+8.2%)
Sep 2016
-
-$104.45M(+55.1%)
Jun 2016
-
-$67.34M(+24.8%)
Mar 2016
-
-$53.94M(-17.2%)
Dec 2015
-$65.15M(-63.6%)
-$65.15M(+3.9%)
Sep 2015
-
-$62.68M(-62.7%)
Jun 2015
-
-$168.26M(+17.9%)
Mar 2015
-
-$142.73M(-20.3%)
Dec 2014
-$179.18M(+162.6%)
-$179.18M(+20.1%)
Sep 2014
-
-$149.13M(+15.1%)
Jun 2014
-
-$129.58M(-6.1%)
Mar 2014
-
-$138.06M(+102.3%)
Dec 2013
-$68.24M(+103.0%)
-$68.24M(+25.7%)
Sep 2013
-
-$54.30M(+25.1%)
Jun 2013
-
-$43.40M(+13.2%)
Mar 2013
-
-$38.35M(>+9900.0%)
Dec 2012
-$33.61M(>+9900.0%)
-
Nov 2012
-
-$146.80K(+2.6%)
Aug 2012
-
-$143.10K(+2.5%)
May 2012
-
-$139.60K(+2.6%)
Feb 2012
-
-$136.10K(+3.3%)
Feb 2012
-$136.10K(+12.2%)
-
Nov 2011
-
-$131.80K(+2.7%)
Aug 2011
-
-$128.30K(+5.8%)
Feb 2011
-$121.30K
-$121.30K

FAQ

  • What is Travere Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Travere Therapeutics?
  • What is Travere Therapeutics annual retained earnings year-on-year change?
  • What is Travere Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Travere Therapeutics?
  • What is Travere Therapeutics quarterly retained earnings year-on-year change?

What is Travere Therapeutics annual retained earnings?

The current annual retained earnings of TVTX is -$1.45B

What is the all time high annual retained earnings for Travere Therapeutics?

Travere Therapeutics all-time high annual retained earnings is -$121.30K

What is Travere Therapeutics annual retained earnings year-on-year change?

Over the past year, TVTX annual retained earnings has changed by -$321.55M (-28.57%)

What is Travere Therapeutics quarterly retained earnings?

The current quarterly retained earnings of TVTX is -$1.49B

What is the all time high quarterly retained earnings for Travere Therapeutics?

Travere Therapeutics all-time high quarterly retained earnings is -$121.30K

What is Travere Therapeutics quarterly retained earnings year-on-year change?

Over the past year, TVTX quarterly retained earnings has changed by -$226.71M (-17.97%)
On this page